drugset / Trial / NCT07697846

A Study to Investigate the Effects of Zovaglutide (ZT002 Injection) on QTc Interval in Healthy Adults

NCT07697846 ↗

Phase 1 Not yet recruiting 40 enrolled Beijing QL Biopharmaceutical Co.,Ltd
RandomizedParallel-groupDouble-blindTreatment

Summary

This study is designed to investigate the effect of treatment with Zovaglutide (ZT002 Injection) on the corrected cardiac QT interval relative to a placebo control in healthy participants.

Timeline

Start
2026-07-18
Primary completion
2027-01-13
Completion
2027-03-24

Drugs

EvaluationDrugModalityDoseRoute
Subject Zovaglutide Unknown — Subcutaneous

Indications